Bioheart
Biotech company focused on the development of effective cell technologies to treat cardiovascular diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD19—28m (Dealroom.co estimates Oct 2014.)
Sunrise Florida (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Early VC | ||
| N/A | $15.0m | Early VC | |
| N/A | N/A | IPO | |
$1.0m | Seed | ||
| N/A | $230k | Seed | |
| N/A | $100k | Seed | |
| N/A | $150k | Seed | |
| N/A | $470k | Seed | |
$3.0m | Early VC | ||
| Total Funding | AUD30.8m | ||